gSpin Technologies

Executive Summary

gSpin Technologies is a San Francisco-based biotech startup founded in 2019 that leverages quantum sensing to transform medical diagnostics. The company is developing two breakthrough products: quantum-boosted MRI coils that enhance imaging resolution and speed, and a non-invasive point-of-care blood analysis device designed to decentralize lab testing. By applying quantum physics to common diagnostic tools, gSpin aims to improve patient outcomes, reduce healthcare costs, and expand access to advanced diagnostics beyond traditional hospital settings. While still in early stages, the company's innovative approach has the potential to disrupt the medical imaging and diagnostics market, pending successful development and regulatory clearance.

Upcoming Catalysts (preview)

• Q4 2026FDA submission for quantum-boosted MRI coils40% success
• Q2 2027First-in-human study results for blood analysis device35% success
• TBDStrategic partnership with major diagnostic OEM50% success